High-dose proton beam therapy for sinonasal mucosal malignant melanoma

被引:43
|
作者
Fuji, Hiroshi [1 ,7 ]
Yoshikawa, Shusuke [2 ]
Kasami, Masako [3 ]
Murayama, Shigeyuki [1 ]
Onitsuka, Tetsuro [4 ,5 ]
Kashiwagi, Hiroya [6 ]
Kiyohara, Yoshio [2 ]
机构
[1] Shizuoka Canc Ctr Hosp, Div Proton Therapy, Shizuoka 4118777, Japan
[2] Shizuoka Canc Ctr Hosp, Div Dermatol, Shizuoka 4118777, Japan
[3] Shizuoka Canc Ctr Hosp, Div Pathl, Shizuoka 4118777, Japan
[4] Shizuoka Canc Ctr Hosp, Div Head Surg, Shizuoka 4118777, Japan
[5] Shizuoka Canc Ctr Hosp, Div Neck Surg, Shizuoka 4118777, Japan
[6] Shizuoka Canc Ctr Hosp, Div Opthalomol, Shizuoka 4118777, Japan
[7] Natl Ctr Child Hlth & Dev, Div Radiat Oncol, Setagaya Ku, Tokyo 1578535, Japan
关键词
Mucosal melanoma; Proton beam therapy; Radiotherapy; Sinonasal melanoma; NASAL CAVITY; HEAD; RADIOTHERAPY; NECK;
D O I
10.1186/1748-717X-9-162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The significance of definitive radiotherapy for sinonasal mucosal melanoma (SMM) is sill controvertial. This study was to evaluate the role of high-dose proton beam therapy (PBT) in patients with SMM. Methods: The cases of 20 patients with SMM localized to the primary site who were treated by PBT between 2006 and 2012 were retrospectively analyzed. The patterns of overall survival and morbidity were assessed. Results: The median follow-up time was 35 months (range, 6-77 months). The 5-year overall and disease-free survival rates were 51% and 38%, respectively. Four patients showed local failure, 2 showed regrowth of the primary tumor, and 2 showed new sinonasal tumors beyond the primary site. The 5-year local control rate after PBT was 62%. Nodal and distant failure was seen in 7 patients. Three grade 4 late toxicities were observed in tumor-involved optic nerve. Conclusion: Our findings suggested that high-dose PBT is an effective local treatment that is less invasive than surgery but with comparable outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Sinonasal malignant mucosal melanoma: case report and critical review of the literature
    Cantone, E.
    Giurazza, F.
    Piro, E.
    Cavaliere, M.
    Ricciardiello, F.
    Di Lullo, A. M.
    FRONTIERA ORL, 2016, 7 (01): : 45 - 55
  • [22] A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
    Kim, Kangpyo
    Yu, Jeong Il
    Park, Hee Chul
    Yoo, Gyu Sang
    Lim, Do Hoon
    Noh, Jae Myoung
    Jeong, Woo Kyoung
    RADIOTHERAPY AND ONCOLOGY, 2022, 176 : 9 - 16
  • [23] TREATMENT OF DISSEMINATED MALIGNANT-MELANOMA WITH HIGH-DOSE ORAL BCG
    VARELLA, AD
    BANDIERA, DC
    DEAMORIM, AR
    CALVIS, LA
    SANTOS, IO
    ESCALEIRA, N
    GENTIL, F
    CANCER, 1981, 48 (06) : 1353 - 1362
  • [24] Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma
    Sara Massaguer
    Marcelo Sánchez
    Teresa Castel
    European Radiology, 2004, 14 : 1716 - 1717
  • [25] Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma
    Massaguer, S
    Sánchez, M
    Castel, T
    EUROPEAN RADIOLOGY, 2004, 14 (09) : 1716 - 1717
  • [26] Clinical target volume design and dose in carbon-ion radiation therapy for sinonasal mucosal melanoma
    Yang, Wan-Chin
    Koto, Masashi
    Ikawa, Hiroaki
    Imai, Reiko
    Shinoto, Makoto
    Takiyama, Hirotoshi
    Isozaki, Tetsuro
    Yamada, Shigeru
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [27] Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
    Nakajima, Koichiro
    Iwata, Hiromitsu
    Hattori, Yukiko
    Nomura, Kento
    Hashimoto, Shingo
    Toshito, Toshiyuki
    Hayashi, Kensuke
    Kuroda, Yo
    Fukano, Hideo
    Ogino, Hiroyuki
    Shibamoto, Yuta
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2021, 8 (01) : 189 - 199
  • [28] Adjuvant high-dose interferon therapy for high-risk melanoma
    Ready, N
    Weinstock, MA
    ARCHIVES OF DERMATOLOGY, 2003, 139 (12) : 1635 - 1637
  • [29] TANTALUM BUTTONS FOR LOCALIZATION OF MALIGNANT-MELANOMA IN PROTON-BEAM THERAPY
    BROCKHURST, RJ
    OPHTHALMIC SURGERY AND LASERS, 1980, 11 (05): : 352 - 352
  • [30] Optic neuropathy after proton-beam therapy for malignant choroidal melanoma
    Meyer, A
    Lévy, C
    Blondel, J
    D'Hermies, F
    Frau, E
    Schlienger, P
    Mammar, H
    Delacroix, S
    Nauraye, C
    Desblancs, C
    Ferrand, R
    Mazal, A
    Asselain, B
    Plancher, C
    Habrand, JL
    Desjardins, L
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2000, 23 (06): : 543 - 553